Global Glucagon Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Glucagon Drug market size was valued at US$ 3572.6 million in 2023. With growing demand in downstream market, the Glucagon Drug is forecast to a readjusted size of US$ 5451.9 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Glucagon Drug market. Glucagon Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon Drug market.
Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Glucagon Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon Drug market. It may include historical data, market segmentation by Type (e.g., Inject Glucagon, Nasal Glucagon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon Drug industry. This include advancements in Glucagon Drug technology, Glucagon Drug new entrants, Glucagon Drug new investment, and other innovations that are shaping the future of Glucagon Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon Drug market.
Market Segmentation:
Glucagon Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Glucagon Drug market?
What factors are driving Glucagon Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon Drug market opportunities vary by end market size?
How does Glucagon Drug break out type, application?
According to our LPI (LP Information) latest study, the global Glucagon Drug market size was valued at US$ 3572.6 million in 2023. With growing demand in downstream market, the Glucagon Drug is forecast to a readjusted size of US$ 5451.9 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Glucagon Drug market. Glucagon Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Glucagon Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Glucagon Drug market.
Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Glucagon Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Glucagon Drug market. It may include historical data, market segmentation by Type (e.g., Inject Glucagon, Nasal Glucagon), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Glucagon Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Glucagon Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Glucagon Drug industry. This include advancements in Glucagon Drug technology, Glucagon Drug new entrants, Glucagon Drug new investment, and other innovations that are shaping the future of Glucagon Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Glucagon Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Glucagon Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Glucagon Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Glucagon Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Glucagon Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Glucagon Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Glucagon Drug market.
Market Segmentation:
Glucagon Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
What is the 10-year outlook for the global Glucagon Drug market?
What factors are driving Glucagon Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucagon Drug market opportunities vary by end market size?
How does Glucagon Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Glucagon Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucagon Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucagon Drug by Country/Region, 2019, 2023 & 2030
2.2 Glucagon Drug Segment by Type
2.2.1 Inject Glucagon
2.2.2 Nasal Glucagon
2.3 Glucagon Drug Sales by Type
2.3.1 Global Glucagon Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Glucagon Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucagon Drug Sale Price by Type (2019-2024)
2.4 Glucagon Drug Segment by Application
2.4.1 Emergency Kits
2.4.2 General Use
2.4.3 Diagnostic & Motility
2.4.4 Cardiogenic Shock
2.4.5 Others
2.5 Glucagon Drug Sales by Application
2.5.1 Global Glucagon Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Glucagon Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucagon Drug Sale Price by Application (2019-2024)
3 GLOBAL GLUCAGON DRUG BY COMPANY
3.1 Global Glucagon Drug Breakdown Data by Company
3.1.1 Global Glucagon Drug Annual Sales by Company (2019-2024)
3.1.2 Global Glucagon Drug Sales Market Share by Company (2019-2024)
3.2 Global Glucagon Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Glucagon Drug Revenue by Company (2019-2024)
3.2.2 Global Glucagon Drug Revenue Market Share by Company (2019-2024)
3.3 Global Glucagon Drug Sale Price by Company
3.4 Key Manufacturers Glucagon Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Drug Product Location Distribution
3.4.2 Players Glucagon Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLUCAGON DRUG BY GEOGRAPHIC REGION
4.1 World Historic Glucagon Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucagon Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucagon Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucagon Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Glucagon Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucagon Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucagon Drug Sales Growth
4.4 APAC Glucagon Drug Sales Growth
4.5 Europe Glucagon Drug Sales Growth
4.6 Middle East & Africa Glucagon Drug Sales Growth
5 AMERICAS
5.1 Americas Glucagon Drug Sales by Country
5.1.1 Americas Glucagon Drug Sales by Country (2019-2024)
5.1.2 Americas Glucagon Drug Revenue by Country (2019-2024)
5.2 Americas Glucagon Drug Sales by Type
5.3 Americas Glucagon Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Drug Sales by Region
6.1.1 APAC Glucagon Drug Sales by Region (2019-2024)
6.1.2 APAC Glucagon Drug Revenue by Region (2019-2024)
6.2 APAC Glucagon Drug Sales by Type
6.3 APAC Glucagon Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Glucagon Drug by Country
7.1.1 Europe Glucagon Drug Sales by Country (2019-2024)
7.1.2 Europe Glucagon Drug Revenue by Country (2019-2024)
7.2 Europe Glucagon Drug Sales by Type
7.3 Europe Glucagon Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Glucagon Drug by Country
8.1.1 Middle East & Africa Glucagon Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucagon Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucagon Drug Sales by Type
8.3 Middle East & Africa Glucagon Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon Drug
10.3 Manufacturing Process Analysis of Glucagon Drug
10.4 Industry Chain Structure of Glucagon Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Drug Distributors
11.3 Glucagon Drug Customer
12 WORLD FORECAST REVIEW FOR GLUCAGON DRUG BY GEOGRAPHIC REGION
12.1 Global Glucagon Drug Market Size Forecast by Region
12.1.1 Global Glucagon Drug Forecast by Region (2025-2030)
12.1.2 Global Glucagon Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Drug Forecast by Type
12.7 Global Glucagon Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Glucagon Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Glucagon Drug Product Portfolios and Specifications
13.2.3 Eli Lilly Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Glucagon Drug Product Portfolios and Specifications
13.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Torrent Labs
13.4.1 Torrent Labs Company Information
13.4.2 Torrent Labs Glucagon Drug Product Portfolios and Specifications
13.4.3 Torrent Labs Glucagon Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Torrent Labs Main Business Overview
13.4.5 Torrent Labs Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Glucagon Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inject Glucagon
Table 4. Major Players of Nasal Glucagon
Table 5. Global Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global Glucagon Drug Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Drug Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 11. Global Glucagon Drug Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Drug Revenue by Application (2019-2024)
Table 13. Global Glucagon Drug Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Glucagon Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global Glucagon Drug Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Drug Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Drug Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Glucagon Drug Producing Area Distribution and Sales Area
Table 21. Players Glucagon Drug Products Offered
Table 22. Glucagon Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Glucagon Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Glucagon Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas Glucagon Drug Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 38. Americas Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 39. APAC Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 40. APAC Glucagon Drug Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Drug Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Drug Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 44. APAC Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 45. Europe Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 46. Europe Glucagon Drug Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 50. Europe Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Glucagon Drug Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon Drug
Table 58. Key Market Challenges & Risks of Glucagon Drug
Table 59. Key Industry Trends of Glucagon Drug
Table 60. Glucagon Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Drug Distributors List
Table 63. Glucagon Drug Customer List
Table 64. Global Glucagon Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Glucagon Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Glucagon Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Glucagon Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Glucagon Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Glucagon Drug Product Portfolios and Specifications
Table 80. Novo Nordisk Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Glucagon Drug Product Portfolios and Specifications
Table 85. Eli Lilly Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Fresenius Kabi Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Kabi Glucagon Drug Product Portfolios and Specifications
Table 90. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Fresenius Kabi Main Business
Table 92. Fresenius Kabi Latest Developments
Table 93. Torrent Labs Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Torrent Labs Glucagon Drug Product Portfolios and Specifications
Table 95. Torrent Labs Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Torrent Labs Main Business
Table 97. Torrent Labs Latest Developments
Table 1. Glucagon Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Glucagon Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inject Glucagon
Table 4. Major Players of Nasal Glucagon
Table 5. Global Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global Glucagon Drug Sales Market Share by Type (2019-2024)
Table 7. Global Glucagon Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global Glucagon Drug Revenue Market Share by Type (2019-2024)
Table 9. Global Glucagon Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 11. Global Glucagon Drug Sales Market Share by Application (2019-2024)
Table 12. Global Glucagon Drug Revenue by Application (2019-2024)
Table 13. Global Glucagon Drug Revenue Market Share by Application (2019-2024)
Table 14. Global Glucagon Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Glucagon Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global Glucagon Drug Sales Market Share by Company (2019-2024)
Table 17. Global Glucagon Drug Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Glucagon Drug Revenue Market Share by Company (2019-2024)
Table 19. Global Glucagon Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Glucagon Drug Producing Area Distribution and Sales Area
Table 21. Players Glucagon Drug Products Offered
Table 22. Glucagon Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Glucagon Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global Glucagon Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Glucagon Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Glucagon Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Glucagon Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global Glucagon Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Glucagon Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas Glucagon Drug Sales Market Share by Country (2019-2024)
Table 35. Americas Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 37. Americas Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 38. Americas Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 39. APAC Glucagon Drug Sales by Region (2019-2024) & (K Units)
Table 40. APAC Glucagon Drug Sales Market Share by Region (2019-2024)
Table 41. APAC Glucagon Drug Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Glucagon Drug Revenue Market Share by Region (2019-2024)
Table 43. APAC Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 44. APAC Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 45. Europe Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 46. Europe Glucagon Drug Sales Market Share by Country (2019-2024)
Table 47. Europe Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 49. Europe Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 50. Europe Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Glucagon Drug Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Glucagon Drug Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Glucagon Drug Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Glucagon Drug Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Glucagon Drug Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Glucagon Drug Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Glucagon Drug
Table 58. Key Market Challenges & Risks of Glucagon Drug
Table 59. Key Industry Trends of Glucagon Drug
Table 60. Glucagon Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Glucagon Drug Distributors List
Table 63. Glucagon Drug Customer List
Table 64. Global Glucagon Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Glucagon Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Glucagon Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Glucagon Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Glucagon Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Glucagon Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Glucagon Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Glucagon Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Glucagon Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Glucagon Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Glucagon Drug Product Portfolios and Specifications
Table 80. Novo Nordisk Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. Eli Lilly Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Glucagon Drug Product Portfolios and Specifications
Table 85. Eli Lilly Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Fresenius Kabi Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Kabi Glucagon Drug Product Portfolios and Specifications
Table 90. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Fresenius Kabi Main Business
Table 92. Fresenius Kabi Latest Developments
Table 93. Torrent Labs Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Torrent Labs Glucagon Drug Product Portfolios and Specifications
Table 95. Torrent Labs Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Torrent Labs Main Business
Table 97. Torrent Labs Latest Developments
LIST OF FIGURES
Figure 1. Picture of Glucagon Drug
Figure 2. Glucagon Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Glucagon Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inject Glucagon
Figure 10. Product Picture of Nasal Glucagon
Figure 11. Global Glucagon Drug Sales Market Share by Type in 2023
Figure 12. Global Glucagon Drug Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Drug Consumed in Emergency Kits
Figure 14. Global Glucagon Drug Market: Emergency Kits (2019-2024) & (K Units)
Figure 15. Glucagon Drug Consumed in General Use
Figure 16. Global Glucagon Drug Market: General Use (2019-2024) & (K Units)
Figure 17. Glucagon Drug Consumed in Diagnostic & Motility
Figure 18. Global Glucagon Drug Market: Diagnostic & Motility (2019-2024) & (K Units)
Figure 19. Glucagon Drug Consumed in Cardiogenic Shock
Figure 20. Global Glucagon Drug Market: Cardiogenic Shock (2019-2024) & (K Units)
Figure 21. Glucagon Drug Consumed in Others
Figure 22. Global Glucagon Drug Market: Others (2019-2024) & (K Units)
Figure 23. Global Glucagon Drug Sales Market Share by Application (2023)
Figure 24. Global Glucagon Drug Revenue Market Share by Application in 2023
Figure 25. Glucagon Drug Sales Market by Company in 2023 (K Units)
Figure 26. Global Glucagon Drug Sales Market Share by Company in 2023
Figure 27. Glucagon Drug Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Glucagon Drug Revenue Market Share by Company in 2023
Figure 29. Global Glucagon Drug Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Glucagon Drug Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Glucagon Drug Sales 2019-2024 (K Units)
Figure 32. Americas Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 33. APAC Glucagon Drug Sales 2019-2024 (K Units)
Figure 34. APAC Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 35. Europe Glucagon Drug Sales 2019-2024 (K Units)
Figure 36. Europe Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Glucagon Drug Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 39. Americas Glucagon Drug Sales Market Share by Country in 2023
Figure 40. Americas Glucagon Drug Revenue Market Share by Country in 2023
Figure 41. Americas Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 42. Americas Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 43. United States Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Glucagon Drug Sales Market Share by Region in 2023
Figure 48. APAC Glucagon Drug Revenue Market Share by Regions in 2023
Figure 49. APAC Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 50. APAC Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 51. China Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Glucagon Drug Sales Market Share by Country in 2023
Figure 59. Europe Glucagon Drug Revenue Market Share by Country in 2023
Figure 60. Europe Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 61. Europe Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 62. Germany Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Glucagon Drug Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Glucagon Drug Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 71. Egypt Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Glucagon Drug in 2023
Figure 77. Manufacturing Process Analysis of Glucagon Drug
Figure 78. Industry Chain Structure of Glucagon Drug
Figure 79. Channels of Distribution
Figure 80. Global Glucagon Drug Sales Market Forecast by Region (2025-2030)
Figure 81. Global Glucagon Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Glucagon Drug Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Glucagon Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Glucagon Drug Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Glucagon Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Glucagon Drug
Figure 2. Glucagon Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Glucagon Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Glucagon Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inject Glucagon
Figure 10. Product Picture of Nasal Glucagon
Figure 11. Global Glucagon Drug Sales Market Share by Type in 2023
Figure 12. Global Glucagon Drug Revenue Market Share by Type (2019-2024)
Figure 13. Glucagon Drug Consumed in Emergency Kits
Figure 14. Global Glucagon Drug Market: Emergency Kits (2019-2024) & (K Units)
Figure 15. Glucagon Drug Consumed in General Use
Figure 16. Global Glucagon Drug Market: General Use (2019-2024) & (K Units)
Figure 17. Glucagon Drug Consumed in Diagnostic & Motility
Figure 18. Global Glucagon Drug Market: Diagnostic & Motility (2019-2024) & (K Units)
Figure 19. Glucagon Drug Consumed in Cardiogenic Shock
Figure 20. Global Glucagon Drug Market: Cardiogenic Shock (2019-2024) & (K Units)
Figure 21. Glucagon Drug Consumed in Others
Figure 22. Global Glucagon Drug Market: Others (2019-2024) & (K Units)
Figure 23. Global Glucagon Drug Sales Market Share by Application (2023)
Figure 24. Global Glucagon Drug Revenue Market Share by Application in 2023
Figure 25. Glucagon Drug Sales Market by Company in 2023 (K Units)
Figure 26. Global Glucagon Drug Sales Market Share by Company in 2023
Figure 27. Glucagon Drug Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Glucagon Drug Revenue Market Share by Company in 2023
Figure 29. Global Glucagon Drug Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Glucagon Drug Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Glucagon Drug Sales 2019-2024 (K Units)
Figure 32. Americas Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 33. APAC Glucagon Drug Sales 2019-2024 (K Units)
Figure 34. APAC Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 35. Europe Glucagon Drug Sales 2019-2024 (K Units)
Figure 36. Europe Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Glucagon Drug Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Glucagon Drug Revenue 2019-2024 ($ Millions)
Figure 39. Americas Glucagon Drug Sales Market Share by Country in 2023
Figure 40. Americas Glucagon Drug Revenue Market Share by Country in 2023
Figure 41. Americas Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 42. Americas Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 43. United States Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Glucagon Drug Sales Market Share by Region in 2023
Figure 48. APAC Glucagon Drug Revenue Market Share by Regions in 2023
Figure 49. APAC Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 50. APAC Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 51. China Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Glucagon Drug Sales Market Share by Country in 2023
Figure 59. Europe Glucagon Drug Revenue Market Share by Country in 2023
Figure 60. Europe Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 61. Europe Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 62. Germany Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Glucagon Drug Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Glucagon Drug Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Glucagon Drug Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Glucagon Drug Sales Market Share by Application (2019-2024)
Figure 71. Egypt Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Glucagon Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Glucagon Drug in 2023
Figure 77. Manufacturing Process Analysis of Glucagon Drug
Figure 78. Industry Chain Structure of Glucagon Drug
Figure 79. Channels of Distribution
Figure 80. Global Glucagon Drug Sales Market Forecast by Region (2025-2030)
Figure 81. Global Glucagon Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Glucagon Drug Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Glucagon Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Glucagon Drug Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Glucagon Drug Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Spirometer Filters Market Growth 2024-2030
US$ 3,660.00
September 2024
156 pages
Global Antimicrobial Peptides Market Growth 2025-2031
US$ 3,660.00
January 2025
108 pages
Global Pelvic Floor Electric Stimulator Market Growth 2023-2029
US$ 3,660.00
March 2023
103 pages
Global Glucose Oxidase Market Growth 2023-2029
US$ 3,660.00
March 2023
94 pages
Global Eisenmenger Syndrome Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
106 pages
